Clinical Trials Browser

Has results × Polycythemia Vera × Hydroxyurea × Clear all

NCT00928707 2019-10-31

PV

Phase 2 Completed

45 enrolled 10 charts

Polycythemia Vera

NCT01243944 2019-03-06

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

Phase 3 Completed

222 enrolled 21 charts

Polycythemia Vera